Evidence map›Paper›PMID 26285805›Full record

ReviewBioscience reports2015

The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis.

Gina A Smith, Gareth W Fearnley, Darren C Tomlinson, Michael A Harrison, Sreenivasan Ponnambalam

Open access · goldAbstract readReview
In one paragraph

Review in Bioscience reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. CD146, from a melanoma cell adhesion molecule to a signaling receptor.Signal transduction and targeted therapy · 2020
    Review
  12. VEGF-A in Cardiomyocytes and Heart Diseases.International journal of molecular sciences · 2020
    Review
  13. The Noonan Syndrome GeneCirculation research · 2020
    Article
  14. Article
  15. Alternative Splicing in Angiogenesis.International journal of molecular sciences · 2019
    Review
  16. Article
  17. Review
  18. Recombinant RGD-disintegrin DisBa-01 blocks integrin αCell communication and signaling : CCS · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gina A SmithSchool of Molecular & Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K.
Gareth W FearnleySchool of Molecular & Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K.
Darren C TomlinsonSchool of Molecular & Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K.
Michael A HarrisonSchool of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, U.K.
Sreenivasan PonnambalamSchool of Molecular & Cellular Biology, University of Leeds, Leeds LS2 9JT, U.K. s.ponnambalam@leeds.ac.uk.
University of Leeds · GB

Funding

British Heart Foundation FS/12/20/29462
6 · The paper itself

Abstract

VEGFs (vascular endothelial growth factors) are a family of conserved disulfide-linked soluble secretory glycoproteins found in higher eukaryotes. VEGFs mediate a wide range of responses in different tissues including metabolic homoeostasis, cell proliferation, migration and tubulogenesis. Such responses are initiated by VEGF binding to soluble and membrane-bound VEGFRs (VEGF receptor tyrosine kinases) and co-receptors. VEGF and receptor splice isoform diversity further enhances complexity of membrane protein assembly and function in signal transduction pathways that control multiple cellular responses. Different signal transduction pathways are simultaneously activated by VEGFR-VEGF complexes with membrane trafficking along the endosome-lysosome network further modulating signal output from multiple enzymatic events associated with such pathways. Balancing VEGFR-VEGF signal transduction with trafficking and proteolysis is essential in controlling the intensity and duration of different intracellular signalling events. Dysfunction in VEGF-regulated signal transduction is important in chronic disease states including cancer, atherosclerosis and blindness. This family of growth factors and receptors is an important model system for understanding human disease pathology and developing new therapeutics for treating such ailments.

Indexed as

AnimalsDrug DiscoveryHumansModels, MolecularProtein TransportProteolysisReceptors, Vascular Endothelial Growth FactorSignal TransductionVascular Endothelial Growth FactorsReceptors, Vascular Endothelial Growth FactorVascular Endothelial Growth Factorsdiseasedrugsisoformsmembrane traffickingreceptor tyrosine kinasesignal transductionvascular endothelial growth factor (VEGF)

Identifiers

PMID26285805
PMCPMC4613718
OpenAlexW1782544073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.